Blog
RSS FeedPosted by Michael Wonder on 21 Aug 2019
Empirical evidence supports critics of Patented Medicine Prices Review Board regulations
21 August 2019 - Canadian Health Policy Institute, a Toronto-based private-sector think-tank established in 2012, has published several studies that bolster ...
Posted by Michael Wonder on 21 Aug 2019
Appealing court ruling, Trump administration renews fight to require drug prices in TV ads
21 August 2019 - The Trump administration isn’t giving up the fight to require drug makers include their sticker prices ...
Posted by Michael Wonder on 20 Aug 2019
Law makers want to lower drug prices. Their plan would end up harming patients.
20 August 2019 - Chronic disease is the leading cause of disability and death in the United States. ...
Posted by Michael Wonder on 20 Aug 2019
Brand name drug prices rising at slower pace, lower amounts
20 August 2019 - Drug companies are still raising prices for brand-name prescription medicines, just not as often or by ...
Posted by Michael Wonder on 20 Aug 2019
A drug maker replaces an old treatment and boosts the price by 1,300%
20 August 2019 - The Trump administration may brag that drug makers are dialing back price hikes, but a company ...
Posted by Michael Wonder on 19 Aug 2019
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
17 August 2019 - AbbVie has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on ...
Posted by Michael Wonder on 19 Aug 2019
Despite their pledges, Democrats haven’t yet lowered drug prices. Here’s how they’re explaining themselves.
19 August 2019 - Republican Chris Pappas strode into the Tri-County Cap, a nondescript office building nestled between a propane ...
Posted by Michael Wonder on 18 Aug 2019
The right’s left turn on drug prices
18 August 2019 - The rate of increase is falling even as the GOP embraces bad ideas. ...
Posted by Michael Wonder on 18 Aug 2019
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
17 August 2019 - Roche has priced its personalised cancer treatment, Rozlytrek, at about $17,050 per month, nearly half of ...
Posted by Michael Wonder on 16 Aug 2019
What will PMPRB drug pricing changes mean for plan sponsors?
15 August 2019 - Private plan sponsors can expect to see lower drug prices resulting from recent changes to the ...
Posted by Michael Wonder on 15 Aug 2019
US politicians round on generics firms for blocking drug pricing probe
15 August 2019 - Renews focus on increases in generic drug prices. ...
Posted by Michael Wonder on 15 Aug 2019
Trump health official: controversial drug pricing move is 'top priority'
15 August 2019 - A top Trump administration health official on Thursday indicated that the administration is pushing forward with ...
Posted by Michael Wonder on 14 Aug 2019
Canadians benefitting from substantially lower generic drug prices
14 August 2019 - Latest agreement between public payers and the Canadian generic industry closes gap with international prices. ...
Posted by Michael Wonder on 14 Aug 2019
The window for Congress to do something on drug prices won’t be open forever
14 August 2019 - It’s do-or-die time on drug pricing when Congress returns to Washington in a few weeks. ...
Posted by Michael Wonder on 14 Aug 2019
U.S. law makers push Mylan, Teva over drug pricing probe
14 August 2019 - The head of the U.S. House of Representative’s oversight panel on Wednesday called on three drug makers ...